ba 41899 has been researched along with Cardiomyopathy, Dilated in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiesi, M; Depersin, H; GrĂ¼ninger, S; Hasenfuss, G; Herzig, JW; Holubarsch, C; Kubalek, R; Leutert, T; Pieske, B; Pioch, K; Wenk, P | 1 |
Brixius, K; Reicke, S; Reuter, H; Schwinger, RH | 1 |
2 other study(ies) available for ba 41899 and Cardiomyopathy, Dilated
Article | Year |
---|---|
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2
Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes | 1996 |
Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Topics: Azocines; Calcium; Calcium Channels; Cardiomyopathy, Dilated; Cardiotonic Agents; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Humans; Myocardial Contraction; Quinolines; Thiadiazines | 2002 |